Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 906

1.

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.

Andradas C, Blasco-Benito S, Castillo-Lluva S, Dillenburg-Pilla P, Diez-Alarcia R, Juanes-García A, García-Taboada E, Hernando-Llorente R, Soriano J, Hamann S, Wenners A, Alkatout I, Klapper W, Rocken C, Bauer M, Arnold N, Quintanilla M, Megías D, Vicente-Manzanares M, Urigüen L, Gutkind JS, Guzmán M, Pérez-Gómez E, Sánchez C.

Oncotarget. 2016 Jun 21. doi: 10.18632/oncotarget.10206. [Epub ahead of print]

2.

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.

Ranieri R, Marasco D, Bifulco M, Malfitano AM.

Recent Pat CNS Drug Discov. 2016 Jun 19. [Epub ahead of print]

PMID:
27334611
3.

The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.

Morell C, Bort A, Vara D, Ramos-Torres A, Rodríguez-Henche N, Díaz-Laviada I.

Prostate Cancer Prostatic Dis. 2016 Jun 21. doi: 10.1038/pcan.2016.19. [Epub ahead of print]

PMID:
27324222
4.

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.

May MB, Glode AE.

Cancer Manag Res. 2016 May 12;8:49-55. doi: 10.2147/CMAR.S81425. eCollection 2016. Review.

5.

Phytochemicals as adjunctive with conventional anticancer therapies.

Farzaei MH, Bahramsoltani R, Rahimi R.

Curr Pharm Des. 2016 May 31. [Epub ahead of print]

PMID:
27262332
6.

Cannabis and Cannabinoids (PDQ®): Patient Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2016 May 27.

PMID:
26389314
Free Books & Documents
7.

Cannabis and Cannabinoids (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2016 May 27.

PMID:
26389198
Free Books & Documents
8.

Cannabis and neuropsychiatry, 1: benefits and risks.

Andrade C.

J Clin Psychiatry. 2016 May;77(5):e551-4. doi: 10.4088/JCP.16f10841.

9.

Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity.

Reece AS, Hulse GK.

Mutat Res. 2016 Jul;789:15-25. doi: 10.1016/j.mrfmmm.2016.05.002. Epub 2016 May 4. Review.

PMID:
27208973
10.

Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review.

van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, Dijkstra D, Mostovaya I, Vissers KC; national guideline working group “Diagnosis treatment of cancer pain”.

Pain Pract. 2016 May 21. doi: 10.1111/papr.12459. [Epub ahead of print] Review.

PMID:
27207115
11.

Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.

Suk KT, Mederacke I, Gwak GY, Cho SW, Adeyemi A, Friedman R, Schwabe RF.

Gut. 2016 May 11. pii: gutjnl-2015-310212. doi: 10.1136/gutjnl-2015-310212. [Epub ahead of print]

PMID:
27196571
12.

Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders.

Manera C, Arena C, Chicca A.

Recent Pat CNS Drug Discov. 2016 May 19. [Epub ahead of print]

PMID:
27193072
13.

Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders.

Ranieri R, Marasco D, Bifulco M, Malfitano AM.

Recent Pat CNS Drug Discov. 2016 May 17. [Epub ahead of print]

PMID:
27184693
14.

ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.

Kaur R, Ambwani SR, Singh S.

Curr Clin Pharmacol. 2016 Apr 17. [Epub ahead of print]

PMID:
27086601
15.

Antitumorigenic targets of cannabinoids - current status and implications.

Ramer R, Hinz B.

Expert Opin Ther Targets. 2016 May 11:1-17. [Epub ahead of print]

PMID:
27070944
16.

Integrating cannabis into clinical cancer care.

Abrams DI.

Curr Oncol. 2016 Mar;23(2):S8-S14. doi: 10.3747/co.23.3099. Epub 2016 Mar 16.

17.

Use of cannabinoids in cancer care: palliative care.

Aggarwal SK.

Curr Oncol. 2016 Mar;23(2):S33-6. doi: 10.3747/co.23.2962. Epub 2016 Mar 16. No abstract available.

18.

Anticancer mechanisms of cannabinoids.

Velasco G, Sánchez C, Guzmán M.

Curr Oncol. 2016 Mar;23(2):S23-32. doi: 10.3747/co.23.3080. Epub 2016 Mar 16. Review.

19.

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A.

Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16.

20.

[Cannabis--Position Paper of the German Respiratory Society (DGP)].

Kreuter M, Nowak D, Rüther T, Hoch E, Thomasius R, Vogelberg C, Brockstedt M, Hellmann A, Gohlke H, Jany B, Loddenkemper R.

Pneumologie. 2016 Feb;70(2):87-97. doi: 10.1055/s-0042-100040. Epub 2016 Mar 2. German.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk